Cabot Stock Forecast, Price & News

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" Cabot stock.
View analyst ratings for Cabot or view top-rated stocks.

6 analysts have issued 12 month price targets for Cabot's stock. Their CBT stock forecasts range from $62.00 to $86.00. On average, they predict Cabot's stock price to reach $75.67 in the next year. This suggests a possible upside of 19.3% from the stock's current price.
View analysts' price targets for Cabot or view top-rated stocks among Wall Street analysts.

Cabot's stock was trading at $56.20 at the start of the year. Since then, CBT shares have increased by 12.9% and is now trading at $63.43.
View the best growth stocks for 2022 here.

Cabot saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 1,990,000 shares, an increase of 25.2% from the May 31st total of 1,590,000 shares. Based on an average daily trading volume, of 442,900 shares, the short-interest ratio is presently 4.5 days.
View Cabot's Short Interest.

Cabot is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for Cabot.

Cabot Co. (NYSE:CBT) announced its quarterly earnings data on Monday, May, 2nd. The specialty chemicals company reported $1.69 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.29. The specialty chemicals company had revenue of $1.09 billion for the quarter, compared to analysts' expectations of $918.99 million. Cabot had a trailing twelve-month return on equity of 29.91% and a net margin of 3.43%. During the same quarter in the prior year, the business earned $1.38 earnings per share.
View Cabot's earnings history.

Cabot announced a quarterly dividend on Friday, May 13th. Stockholders of record on Friday, May 27th will be paid a dividend of $0.37 per share on Friday, June 10th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 2.33%. The ex-dividend date of this dividend is Thursday, May 26th.
View Cabot's dividend history.

Cabot(NYSE:CBT) pays an annual dividend of $1.48 per share and currently has a dividend yield of 2.25%. Cabot does not yet have a strong track record of dividend growth. The dividend payout ratio of Cabot is 65.78%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cabot will have a dividend payout ratio of 19.53% next year. This indicates that Cabot will be able to sustain or increase its dividend.
View Cabot's dividend history.

Cabot updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of $5.80-$6.20 for the period, compared to the consensus estimate of $5.80. The company issued revenue guidance of -.

40 employees have rated Cabot CEO Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among Cabot's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Cabot include LyondellBasell Industries (LYB), Westlake (WLK), Kronos Worldwide (KRO), Hawkins (HWKN), Koppers (KOP), Tredegar (TG) and Trecora Resources (TREC).
View all of CBT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Coca-Cola (KO).

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Cabot's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.25%), Vanguard Group Inc. (10.85%), Wellington Management Group LLP (6.28%), Earnest Partners LLC (5.39%), Fuller & Thaler Asset Management Inc. (4.74%) and LSV Asset Management (3.43%). Company insiders that own Cabot stock include Hobart Kalkstein, Karen A Kalita, Karen A Kalita, Sean D Keohane and Sean D Keohane.
View institutional ownership trends for Cabot.

CBT stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Fuller & Thaler Asset Management Inc., LSV Asset Management, Russell Investments Group Ltd., Royal Bank of Canada, Foundry Partners LLC, Prudential Financial Inc., and Strs Ohio. Company insiders that have sold Cabot company stock in the last two years include Hobart Kalkstein, Karen A Kalita, and Sean D Keohane.
View insider buying and selling activity for Cabot or view top insider-selling stocks.

CBT stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., GMT Capital Corp, Vanguard Group Inc., Wellington Management Group LLP, Invesco Ltd., Lombard Odier Asset Management Europe Ltd, Leeward Investments LLC MA, and Boston Partners.
View insider buying and selling activity for Cabot or or view top insider-buying stocks.

Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CBT stock can currently be purchased for approximately $63.43.

Cabot (NYSE:CBT) has a market capitalization of $3.58 billion and generates $3.41 billion in revenue each year. The specialty chemicals company earns $250 million in net income (profit) each year or $2.25 on an earnings per share basis.

Cabot employs 4,500 workers across the globe.

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The official website for Cabot is www.cabot-corp.com. The specialty chemicals company can be reached via phone at (617) 345-0100, via email at [email protected], or via fax at 617-342-6103.